adalimumab - CISMeF

Preferred Label : adalimumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0422769;

UMLS CUI

C1122087;

Automatic exact mappings (from CISMeF team)
- adalimumab [EMDN type]
Currated CISMeF NLP mapping
- Adalimumab [LOINC component]
- Adalimumab [Anticorps monoclonal]
- Adalimumab [ICD-11 Extension code]
- Adalimumab [SMS substance]
- Adalimumab [NCIt concept]
- Adalimumab (substance) [SNOMED CT concept]
- adalimumab [Substance BNPC]
- adalimumab [International Nonproprietary Name]
MeSH narrower concept(s)
- Adalimumab-adbm [MeSH concept]
- Adalimumab-atto [MeSH concept]
- Amjevita [MeSH concept]
- Cyltezo [MeSH concept]
- D2E7 Antibody [MeSH concept]
- humira [MeSH concept]
Related record
- Adalimumab [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing adalimumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Adalimumab [LOINC component]
- Adalimumab [NCIt concept]
- Adalimumab (substance) [SNOMED CT concept]
- Product containing adalimumab (medicinal product) [SNOMED CT concept]
- adalimumab [ATC Code]
- adalimumab [Substance BNPC]
- adalimumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- adalimumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients